I
IRWD
Ironwood
1.92
0.42+28.00%After Hours: 1.850 -0.07 -3.64%19:56 10/31 EDT
OPEN/PREV CLOSE1.650/1.500
TODAY RANGE1.610-1.940
VOL4.36M
MARKET CAP311.87M
52 WEEK RANGE0.5271-5.13
AVG VOL (3M)1.35M
% TURNOVER2.68%
TURNOVER--
P/E (TTM)-30.9179
% RANGE20.33%
EPS(TTM)-0.0621
P/E(FORWARD)10.67
P/B-1.0120
BVPS-1.8972
DIVIDEND--
P/S0.8753
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP302.78M
SHARES OUTSTANDING162.43M
NEXT EARNINGS11/05-11/10
FREE FLOAT157.70M
LOT SIZE1
EX-DATE04/02/2019
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Ironwood surges 28% as beneficiary of partner AbbVie's Linzess Q3 sales
TipRanks·2d ago
Ironwood jumps after AbbVie reports Linzess sales beat
Benzinga·2d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Simply Wall St·10/17 10:35
Ironwood Pharmaceuticals (NASDAQ:IRWD investor three-year losses grow to 84% as the stock sheds US$36m this past week
NASDAQ·10/16 11:56
BioCryst (BCRX) Soars 6.1%: Is Further Upside Left in the Stock?
NASDAQ·10/15 13:17
Teladoc Health Expands Clarity Platform With Workplace Safety Tool
NASDAQ·10/14 14:57
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery
Barchart·10/11 06:42
Ironwood Pharma Board Member Resigns for New Role
Benzinga·09/30 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
NASDAQ·09/22 13:50
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Simply Wall St·09/10 11:14
Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Share Price Boosted 33% But Its Business Prospects Need A Lift Too
Benzinga·09/04 09:42
Why American Eagle Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
TipRanks·09/03 20:33
Ironwood Pharma Regains Nasdaq Compliance
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.